GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sonoscape Medical Corp (SZSE:300633) » Definitions » Additional Paid-In Capital

Sonoscape Medical (SZSE:300633) Additional Paid-In Capital : ¥0 Mil(As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Sonoscape Medical Additional Paid-In Capital?


Sonoscape Medical's quarterly additional paid-in capital increased from Sep. 2023 (¥0 Mil) to Dec. 2023 (¥1,011 Mil) but then stayed the same from Dec. 2023 (¥1,011 Mil) to Mar. 2024 (¥0 Mil).

Sonoscape Medical's annual additional paid-in capital declined from Dec. 2021 (¥957 Mil) to Dec. 2022 (¥931 Mil) but then increased from Dec. 2022 (¥931 Mil) to Dec. 2023 (¥1,011 Mil).


Sonoscape Medical Additional Paid-In Capital Historical Data

The historical data trend for Sonoscape Medical's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sonoscape Medical Additional Paid-In Capital Chart

Sonoscape Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 268.56 242.27 957.39 931.32 1,011.10

Sonoscape Medical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1,011.10 - 1,011.10 -

Sonoscape Medical Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Sonoscape Medical Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Sonoscape Medical's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Sonoscape Medical (SZSE:300633) Business Description

Traded in Other Exchanges
N/A
Address
Yuquan Road, 10th Floor,Yizhe Building, Nanshan District, Guangdong Province, Shenzhen, CHN, 518051
Sonoscape Medical Corp is a Chinese manufacturer of medical devices for ultrasound diagnostic systems and transducers. The company's product categories include Ultrasound, Endoscope which also includes video equipment, and Electrocardiography consisting of veterinary ECG and resting ECG. Ultrasound category covers color Doppler trolley systems, color Doppler HCU, B/W trolley systems, and probe, among others. The organization has a business presence in China and in other countries.

Sonoscape Medical (SZSE:300633) Headlines

No Headlines